ACN
70
14
ESS
57
6
REGN
53
-3
HCP
47
-2
ILMN
61
-4
PYPL
52
7
MAC
74
3
MSI
73
3
FOXA
44
3
WEC
51
6
AN
49
3
EXR
46
2
CVX
32
3
GLW
55
2
URBN
50
2
HRB
55
3
GE
67
2
NTAP
64
3
FOX
33
2
KMX
58
4
ACN
70
14
ESS
57
6
REGN
53
-3
HCP
47
-2
ILMN
61
-4
PYPL
52
7
MAC
74
3
MSI
73
3
FOXA
44
3
WEC
51
6
AN
49
3
EXR
46
2
CVX
32
3
GLW
55
2
URBN
50
2
HRB
55
3
GE
67
2
NTAP
64
3
FOX
33
2
KMX
58
4
Financhill
Back

First Citizens BancShares Vs. Kymera Therapeutics Industry Stock Comparison

Buy
65

FCNCA
First Citizens BancShares

Last Price:
2,085.91
Seasonality Move:
5.2%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Buy
65
First Citizens BancShares (FCNCA) is a Buy

Is First Citizens BancShares a Buy, Sell or Hold?

  • The current First Citizens BancShares [FCNCA] share price is $2,043.81. The Score for FCNCA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • FCNCA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FCNCA Stock Price Chart

What is First Citizens BancShares's stock price today?

  • The First Citizens BancShares share price today is $2,043.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCNCA is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

FCNCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 31.9 Buy
Relative Strength Index (14 RSI): 65.28 Buy
Chaikin Money Flow: 2528 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1844.11 - 1989.13) Buy
Bollinger Bands (100): (1719.52 - 1998.08) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

FCNCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1998.75 Buy
20-day SMA: 1928.46 Buy
50-day SMA: 1942.41 Buy
200-day SMA: 1713.53 Buy
8-day EMA: 1998.56 Buy
20-day EMA: 1953.13 Buy
50-day EMA: 1922.13 Buy
200-day EMA: 1734.38 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

First Citizens BancShares Earnings Growth & FCNCA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $18.17 per share, and a decrease next year of $11.37 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

First Citizens BancShares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):